Nursing 150 Exam 3 Medications (100+ Questions) – Anticoagulants, Ulcerative Colitis & Crohn’s Drugs, PUD Regimens, Diabetes Meds (Insulin, Oral Hypoglycemics), Lab Values & Mechanisms

This comprehensive and pharmacologically focused resource features 100+ verified exam-style questions and answers for Nursing 150 – Pharmacology and Lab Values, structured for the 2025/2026 academic year at the University of Nursing Sciences. It is the definitive medication and lab reference for Exam 3, covering systemic drugs used in vascular disorders, GI diseases, and endocrine dysfunction, with emphasis on clinical mechanisms, side effects, and nursing considerations. Covered medication classes and topics include: Vascular & Coagulation Therapy: Heparin, Warfarin, Enoxaparin: routes, dosing, antidotes (Protamine sulfate, Vitamin K), INR goals, drug overlap Heparin-induced thrombocytopenia (HIT): alternatives (Argatroban, Lepirudin) DVT Prevention: Xarelto, Fragmin, Arixtra GI Medications: Ulcerative Colitis & Crohn’s Disease: 5-ASA agents: Sulfasalazine, Mesalamine Corticosteroids: Prednisone Immunomodulators: Azathioprine, Cyclosporine Biologics (MABs): Adalimumab, Infliximab, Ustekinumab, Vedolizumab Antibiotics: Metronidazole, Ciprofloxacin Kinase Inhibitors: Upadacitinib (with major safety warnings including CV risks and food restrictions) Peptic Ulcer Disease (PUD): Antacids: Maalox, Mylanta H2 Blockers: Famotidine (Pepcid) PPIs: Pantoprazole, Esomeprazole Mucosal Protectants: Sucralfate H. pylori Regimens: Quad therapy with antibiotics Endocrine & Diabetic Pharmacology: Biguanides: Metformin – mechanism, lactic acidosis risk with contrast Sulfonylureas & Meglitinides: Glimepiride, Glyburide, Repaglinide – insulin stimulation, hypoglycemia risk Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone – fluid retention, heart failure, and bladder cancer risks DPP-4 Inhibitors: Sitagliptin, Linagliptin – infection and skin reactions GLP-1 Agonists: Liraglutide, Dulaglutide – slow digestion, pancreatitis SGLT2 Inhibitors: Canagliflozin, Dapagliflozin – prevent glucose reabsorption, cause UTIs and yeast infections Insulin types: Rapid-acting: Lispro, Aspart Short-acting: Regular Intermediate: NPH Long-acting: Glargine, Detemir Onset, peak, and duration of action detailed Electrolytes & Lab Values (Essential for Medication Monitoring): Sodium, Potassium, Calcium, Magnesium, Phosphorus RBC, WBC, Hgb, Hct, Platelets BUN, Creatinine, Creatinine Clearance A1C levels, glucose ranges for prediabetes, diabetes diagnosis, and glucose thresholds for insulin initiation This resource is structured to improve clinical decision-making, drug safety, and exam success by linking pharmacological action to pathophysiological understanding. It is highly valuable for both exam preparation and real-world medication administration scenarios. Courses this document may concern: Nursing 150: Pharmacology & Med-Surg Nursing GI, Endocrine & Cardiovascular Pharmacology Clinical Nursing Practice Lab Interpretation for Nurses NCLEX-RN & HESI/ATI Pharm Prep Students this document may benefit: BSN and ADN nursing students LPN/LVN students preparing for RN bridge NCLEX-RN, ATI, or HESI pharmacology exam candidates International nurses preparing for U.S. medication safety standards Keywords: heparin, warfarin, enoxaparin, anticoagulants, protamine sulfate, vitamin K, biologics, MABs, sulfasalazine, prednisone, mesalamine, azathioprine, ciprofloxacin, infliximab, kinase inhibitors, upadacitinib, peptic ulcer meds, sucralfate, PPIs, H2 blockers, metformin, insulin types, GLP-1 agonists, DPP-4 inhibitors, SGLT2 inhibitors, TZDs, sulfonylureas, meglitinides, A1C ranges, electrolyte values, nursing pharmacology, Nursing 150 medications, NCLEX pharm prep